Drugs / herpes zoster vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07546669 | Jan 2027 → Dec 2029 expected | glioblastoma | University Hospital, Essen | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | herpes zoster vaccine | “In the randomized intervention arm, patients receive an EMA-approved, inactivated herpes zoster vaccine postoperatively, followed by standard radiotherapy or radiochemotherapy...” NCT07546669 ↗ |
| Modality | Vaccine | “EMA-approved, inactivated herpes zoster vaccine” NCT07546669 ↗ |